# Allogeneic Stem Cell Transplantation for Children With CML

> **NCT02707393** · PHASE2,PHASE3 · COMPLETED · sponsor: **St. Anna Kinderkrebsforschung** · enrollment: 13 (actual)

## Conditions studied

- Chronic Myeloid Leukemia

## Interventions

- **DRUG:** Fludarabine
- **DRUG:** Thiotepa
- **DRUG:** Melphalan
- **DRUG:** ATG
- **DRUG:** Cyclosporine A
- **DRUG:** Mycophenolate mofetil
- **BIOLOGICAL:** bone marrow or peripheral blood stem cells

## Key facts

- **NCT ID:** NCT02707393
- **Lead sponsor:** St. Anna Kinderkrebsforschung
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04-30
- **Primary completion:** 2020-12-01
- **Final completion:** 2020-12-01
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2021-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02707393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02707393, "Allogeneic Stem Cell Transplantation for Children With CML". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02707393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*